Notice of Closed Meeting, 14941-14942 [2020-05262]

Download as PDF Federal Register / Vol. 85, No. 51 / Monday, March 16, 2020 / Notices lotter on DSKBCFDHB2PROD with NOTICES Total capital and start-up costs: The Rule imposes no appreciable current capital or start-up costs. The vast majority of warrantors have already developed systems to retain the records and provide the disclosures required by the Rule. Rule compliance does not require the use of any capital goods, other than ordinary office equipment, to which providers already have access. The Rule imposes one additional cost on IDSMs operating under the rule, which is the annual audit requirement. According to representatives of the IDSMs, the vast majority of costs associated with this requirement consist of the fees paid to the auditors and their staffs. Representatives of the IDSMs previously estimated a combined cost of $300,000 associated with the audits. Staff retains that estimate. Other non-labor costs: As discussed above, staff assumes that approximately twenty percent of dispute files (approximately 2,448 files) are requested by consumers. Staff also estimates that only five percent of consumers will request a copy of the IDSM’s audit report (approximately 612 audit reports).10 Staff bases this assumption on the number of consumer requests received by the IDSMs in the past and the fact that the IDSMs’ annual audits are available online. Staff estimates that the average disputerelated file contains 35 pages and a typical annual audit file contains approximately 200 pages. Staff estimates copying costs of 7 cents per page. Thus, the total annual copying cost for dispute-related files is approximately $5,998 (35 pages per file × $0.07 per page × 2,448 disputes) and the total annual copying cost for annual audit reports is approximately $8,568 (200 pages per audit report × $0.07 per page × 612 audit reports). Accordingly, the total cost attributed to copying under the Rule is approximately $14,566. Thus, the total non-labor cost under the Rule is approximately $314,566 ($300,000 for auditor fees + $14,566 for copying costs). Request for Comments Pursuant to Section 3506(c)(2)(A) of the PRA, the FTC invites comments on: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of 10 This estimate assumes each dispute is associated with one consumer. VerDate Sep<11>2014 18:29 Mar 13, 2020 Jkt 250001 the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of maintaining records, providing reports to the government and providing disclosures to consumers. All comments must be received on or before May 15, 2020. You can file a comment online or on paper. For the FTC to consider your comment, we must receive it on or before May 15, 2020. Write ‘‘Dispute Settlement Rule; PRA Comment: FTC File No. P072108’’ on your comment. Postal mail addressed to the Commission is subject to delay due to heightened security screening. As a result, we encourage you to submit your comments online. To make sure that the Commission considers your online comment, you must file it through the https://www.regulations.gov website by following the instructions on the webbased form provided. Your comment— including your name and your state— will be placed on the public record of this proceeding, including the https:// www.regulations.gov website. If you file your comment on paper, write ‘‘Dispute Settlement Rule; PRA Comment: FTC File No. P072108’’ on your comment and on the envelope, and mail your comment to the following address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW, Suite CC– 5610 (Annex J), Washington, DC 20580, or deliver your comment to the following address: Federal Trade Commission, Office of the Secretary, Constitution Center, 400 7th Street SW, 5th Floor, Suite 5610 (Annex J), Washington, DC 20024. If possible, submit your paper comment to the Commission by courier or overnight service. Because your comment will be placed on the public record, you are solely responsible for making sure that your comment does not include any sensitive or confidential information. In particular, your comment should not include any sensitive personal information, such as your or anyone else’s Social Security number; date of birth; driver’s license number or other state identification number, or foreign country equivalent; passport number; financial account number; or credit or debit card number. You are also solely responsible for making sure that your comment does not include any sensitive health information, such as medical records or other individually identifiable health information. In addition, your comment should not include any ‘‘trade secret or any commercial or financial information PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 14941 which . . . is privileged or confidential’’—as provided by Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— including in particular competitively sensitive information such as costs, sales statistics, inventories, formulas, patterns, devices, manufacturing processes, or customer names. Comments containing material for which confidential treatment is requested must be filed in paper form, must be clearly labeled ‘‘Confidential,’’ and must comply with FTC Rule 4.9(c). In particular, the written request for confidential treatment that accompanies the comment must include the factual and legal basis for the request, and must identify the specific portions of the comment to be withheld from the public record.11 Your comment will be kept confidential only if the General Counsel grants your request in accordance with the law and the public interest. Once your comment has been posted publicly at www.regulations.gov, we cannot redact or remove your comment unless you submit a confidentiality request that meets the requirements for such treatment under FTC Rule 4.9(c), and the General Counsel grants that request. The FTC Act and other laws that the Commission administers permit the collection of public comments to consider and use in this proceeding as appropriate. The Commission will consider all timely and responsive public comments that it receives on or before May 15, 2020. You can find more information, including routine uses permitted by the Privacy Act, in the Commission’s privacy policy, at https:// www.ftc.gov/site-information/privacypolicy. Josephine Liu, Assistant General Counsel for Legal Counsel. [FR Doc. 2020–05266 Filed 3–13–20; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of 11 See E:\FR\FM\16MRN1.SGM FTC Rule 4.9(c). 16MRN1 14942 Federal Register / Vol. 85, No. 51 / Monday, March 16, 2020 / Notices lotter on DSKBCFDHB2PROD with NOTICES the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— GH16–003, Conducting Public Health Research in Thailand: technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH); GH19–003, Advancing Infectious Disease Detection and Response in Senegal; GH19–005, Advancing Public Health Research in Bangladesh; GH19–006, Advancing Infectious Disease Detection and Response in Indonesia; GH19–008, Acute Febrile Illness in Uganda; GH19– 009, Advancing Infectious Disease Detection and Response in Viet Nam; and GH19–010, Advancing Disease Detection and Response in Nigeria. Date: April 21, 2020 Time: 9:00 a.m.—2:00 p.m., EDT Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Hylan Shoob, Ph.D., Scientific Review Officer, Center for Global Health, CDC, 1600 Clifton Road NE, Atlanta, Georgia 30329–4027, Telephone (404) 639–4796; HShoob@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–05262 Filed 3–13–20; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 18:29 Mar 13, 2020 Jkt 250001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–20–20KW; Docket No. CDC–2020– 0030] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled School Health Profiles Test-Retest Reliability Study. CDC is requesting a one-year approval to conduct the School Health Profiles Test-Retest Reliability Study, a study to test the reliability of the data collected through the School Health Profiles questionnaires administered by state and local agencies to principals and lead health education teachers in public secondary schools containing at least one of grades 6 through 12 in the United States. DATES: CDC must receive written comments on or before May 15, 2020. ADDRESSES: You may submit comments, identified by Docket No. CDC–2020– 0030 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, SUMMARY: PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS– D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project School Health Profiles Test-Retest Reliability Study—New—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The purpose of this request is to obtain OMB approval to conduct the School Health Profiles Test-Retest Reliability Study to establish the reliability of the School Health Profiles (‘‘Profiles’’). Profiles is a system of school-based surveys conducted by state and local education and health agencies E:\FR\FM\16MRN1.SGM 16MRN1

Agencies

[Federal Register Volume 85, Number 51 (Monday, March 16, 2020)]
[Notices]
[Pages 14941-14942]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05262]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of

[[Page 14942]]

the Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, CDC, pursuant to Public Law 92-463. The grant 
applications and the discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--GH16-003, Conducting Public 
Health Research in Thailand: technical collaboration with the Ministry 
of Public Health in the Kingdom of Thailand (MOPH); GH19-003, Advancing 
Infectious Disease Detection and Response in Senegal; GH19-005, 
Advancing Public Health Research in Bangladesh; GH19-006, Advancing 
Infectious Disease Detection and Response in Indonesia; GH19-008, Acute 
Febrile Illness in Uganda; GH19-009, Advancing Infectious Disease 
Detection and Response in Viet Nam; and GH19-010, Advancing Disease 
Detection and Response in Nigeria.
    Date: April 21, 2020
    Time: 9:00 a.m.--2:00 p.m., EDT
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Hylan Shoob, Ph.D., Scientific 
Review Officer, Center for Global Health, CDC, 1600 Clifton Road NE, 
Atlanta, Georgia 30329-4027, Telephone (404) 639-4796; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-05262 Filed 3-13-20; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.